SEC Tracker
Get the app
TMCI · XBRL financial data

Treace Medical Concepts financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (TMCI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue40,75862,212*51,10844,45545,08668,708*52,57047,38750,21462,519*47,19845,376
Cost of goods and services sold7,99811,469*10,1278,7818,95413,231*10,6779,63510,50812,118*9,7919,769
Gross profit32,76050,743*40,98135,67436,13255,477*41,89337,75239,70650,401*37,40735,607
Research and development4,3504,152*5,2595,1574,9635,210*5,5625,4984,6804,542*4,6224,376
General and administrative12,68613,449*14,36214,21813,52813,612*15,79116,14416,28114,528*16,17715,249
Total operating expenses50,57857,525*59,94957,05651,26655,681*57,47554,72655,38256,323*54,57450,565
Other operating income (expense)2396*7411220118*1301229288*275202
Operating income (loss)(17,818)(6,782)*(18,968)(21,382)(15,134)(204)*(15,582)(16,974)(15,676)(5,922)*(17,167)(14,958)
Interest expense1,2961,304*1,3171,3121,3131,314*1,3111,3211,3381,350*1,5701,562
Other income (expense)297501*292176(226)(297)*(340)(424)(612)(3,472)*(794)(915)
Income tax expense (benefit)—year only———year only———year only——
Net income (loss)(17,521)(6,281)*(18,676)(21,206)(15,360)(501)*(15,922)(17,398)(16,288)(9,394)*(17,961)(15,873)
Earnings per share, basic USD per share(0.28)(0.10)*(0.30)(0.34)(0.25)(0.01)*(0.25)(0.28)(0.26)(0.15)*(0.28)(0.24)
Earnings per share, diluted USD per share(0.28)(0.10)*(0.30)(0.34)(0.25)(0.01)*(0.25)(0.28)(0.26)(0.15)*(0.28)(0.24)
Weighted average shares, basic thousands of shares61,56261,699*61,79362,08162,22962,341*62,66163,00763,51563,876*64,59365,050
Weighted average shares, diluted thousands of shares61,56261,699*61,79362,08162,22962,341*62,66163,00763,51563,876*64,59365,050

Balance sheet

CSV

Fiscal quarters (TMCI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents7,27812,9829,33418,18112,11011,35013,3728,0527,68610,7089,54412,610
Marketable securities114,885110,216100,67276,86570,68964,32762,71761,23749,73037,65942,31033,009
Accounts receivable24,99638,06330,08325,55924,17740,80331,11030,33332,95942,15530,35828,732
Inventory29,31229,24535,86041,27943,61139,25537,94042,39741,42436,03136,36639,542
Prepaid and other current assets10,6717,85311,4489,6687,0155,6674,2985,5836,1985,5014,8936,561
Total current assets187,142198,359187,397171,552157,602161,402149,437147,602137,997132,054123,471120,454
Property and equipment, net21,53622,29824,51724,24525,16825,95327,12929,70829,97029,75232,06332,496
Right-of-use asset9,4599,2649,0648,7758,5698,4428,2418,0427,8337,6147,3717,139
Goodwill12,81512,81512,81512,81512,81512,81512,81512,81512,81512,81512,81512,815
Total assets240,360251,907242,726226,083212,924217,094205,846206,443196,591190,581184,102181,055
Accounts payable8,68011,83521,14918,07318,64910,52213,22319,95916,1036,72613,53716,061
Accrued liabilities8,93610,45815,15513,7308,0987,1976,0086,1927,3155,7845,9786,281
Total current liabilities33,15445,03347,04944,44638,26334,92533,18041,90040,90830,63534,49141,496
Long-term debt52,93453,00853,08353,15753,23153,30653,38053,45453,52955,58355,82056,042
Lease liability, non-current16,37515,89116,16616,30216,48715,93413,90813,43712,93013,98213,55113,091
Total liabilities102,500113,969116,335113,942108,018104,202100,505108,828107,404103,249106,911113,318
Accumulated deficit(127,966)(134,247)(152,923)(174,129)(189,489)(189,990)(205,912)(223,310)(239,598)(248,992)(266,953)(282,826)
Total stockholders' equity137,860137,938126,391112,141104,906112,892105,34197,61589,18787,33277,19167,737
Total liabilities and equity240,360251,907242,726226,083212,924217,094205,846206,443196,591190,581184,102181,055
Common shares outstanding (cover page) thousands of shares61,67661,75562,00862,19062,29762,61962,90563,17363,71864,59164,87365,035

Cash flows

CSV

Fiscal quarters (TMCI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(17,521)(6,281)*(18,676)(21,206)(15,360)(501)*(15,922)(17,398)(16,288)(9,394)*(17,961)(15,873)
Stock-based compensation5,192*5,872*7,4086,740*7,900*8,555*8,6939,577*7,998*7,555*8,0346,463*
Depreciation and amortization1,564*1,769*1,9092,116*2,157*2,237*2,4612,576*2,778*2,808*8991,888*
Net cash from operating activities(9,513)*532*(7,221)(13,897)*(11,842)*(4,207)*4,198(3,050)*(9,092)*(8,026)*7,240(4,698)*
Purchases of property and equipment3,501*2,248*3,9271,729*2,863*3,074*3,5434,767*2,809*2,398*3,0622,201*
Net cash from investing activities4,597*5,007*3,75822,433*5,763*3,421*(1,894)(3,257)*8,736*9,666*(7,816)7,068*
Repayments of long-term debt—year only——————————
Net cash from financing activities159*165*(185)311*8*26*(282)987*(10)*1,382*(588)696*
Net change in cash(4,757)*5,704*(3,648)8,847*(6,071)*(760)*2,022(5,320)*(366)*3,022*(1,164)3,066*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Treace Medical Concepts12,61045,376(4,698)*65.0M9.7 quarters 10-QJun 30, 2026
Bioventus30,709142,44220,658*not reported— 10-QSep 26, 2026
SS Innovations International13,647not reported(4,235)*200.4M3.2 quarters 10-QJun 30, 2026
SANUWAVE Health9,3769,739425*8.6M— 10-QJun 30, 2026
NeuroPace12,53822,826(3,903)*34.3M13.2 quarters 10-QJun 30, 2026
Cerus16,35057,7143,007*202.0M— 10-QSep 30, 2026
Electromed20,45019,417*2,994*8.4M— 10-KJun 30, 2026
Tactile Systems Technology75,11091,85811,978*22.4M— 10-QSep 30, 2026
Orasure Technologies160,58230,639(9,921)*69.0M16.2 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.